ClinicalTrialsFinder

Non-alcoholic Fatty Liver Disease NAFLD Clinical Trials in San Antonio, Texas

1 recruitingSan Antonio, Texas

Showing 1–1 of 1 trials

Recruiting
Phase 1

Evaluating the Pharmacokinetics and Safety of Miricorilant

Nonalcoholic Steatohepatitis (NASH)Non-alcoholic Fatty Liver Disease NAFLDMetabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis+1 more
Corcept Therapeutics15 enrolled1 locationNCT07553663